Literature DB >> 26033729

Combination Therapy against Polymicrobial Infection, Including by NDM-1-Producing Enterobacteriaceae Resistant to Colistin.

Itaru Nakamura1, Natsuki Sakamoto2, Yukiko Ida2, Ryutaro Imai2, Kotaro Aoki3, Rina Ando4, Tetsuo Yamaguchi3, Hajime Matsumura2, Tetsuya Matsumoto5.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26033729      PMCID： PMC4505272          DOI： 10.1128/AAC.00746-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

1.  'Break-point Checkerboard Plate' for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa.

Authors:  Kazuhiro Tateda; Yoshikazu Ishii; Tetsuya Matsumoto; Keizo Yamaguchi
Journal:  Scand J Infect Dis       Date:  2006

2.  Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis.

Authors:  Neil R H Stone; Neil Woodford; David M Livermore; Julia Howard; Rachel Pike; Shazad Mushtaq; Claire Perry; Susan Hopkins
Journal:  J Antimicrob Chemother       Date:  2011-08-16       Impact factor: 5.790

3.  First report of blaNDM-1 in Raoultella ornithinolytica.

Authors:  Atul Khajuria; Ashok Kumar Praharaj; Naveen Grover; Mahadevan Kumar
Journal:  Antimicrob Agents Chemother       Date:  2012-11-19       Impact factor: 5.191

4.  Bactericidal activity of multiple combinations of tigecycline and colistin against NDM-1-producing Enterobacteriaceae.

Authors:  Mahableshwar Albur; Alan Noel; Karen Bowker; Alasdair MacGowan
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

5.  Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.

Authors:  T Tängdén; R A Hickman; P Forsberg; P Lagerbäck; C G Giske; O Cars
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

6.  In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa.

Authors:  George A Pankey; Deborah S Ashcraft
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Treatment options for New Delhi metallo-beta-lactamase-harboring enterobacteriaceae.

Authors:  Benjamin A Rogers; Hanna E Sidjabat; Anna Silvey; Tara L Anderson; Shalini Perera; Jian Li; David L Paterson
Journal:  Microb Drug Resist       Date:  2013-01-18       Impact factor: 3.431

8.  New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada.

Authors:  Michael R Mulvey; Jennifer M Grant; Katherine Plewes; Diane Roscoe; David A Boyd
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883
  8 in total
  4 in total

1.  Imipenem plus Fosfomycin as Salvage Therapy for Vertebral Osteomyelitis.

Authors:  Itaru Nakamura; Tetsuo Yamaguchi; Kotaro Aoki; Yuri Miura; Satoko Sato; Hiroaki Fujita; Hidehiro Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

Review 2.  Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

Authors:  Jesús Rodríguez-Baño; Belén Gutiérrez-Gutiérrez; Isabel Machuca; Alvaro Pascual
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

Review 3.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

4.  Combination antibiotic therapy for treatment of a patient with infected prosthesis and peri-prosthetic abscess due to Klebsiella pneumoniae harboring New Delhi Metallo (NDM) beta-lactamase.

Authors:  Monica Cespedes Santana; Ting Ting Wong; Carl Urban; Noriel Mariano; Janice Burns; George D Rodriguez; Elan Goldwyn; Nishant Prasad; Sorana Segal-Maurer
Journal:  IDCases       Date:  2022-01-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.